查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1840809

跳蚤、蜱虫和心丝虫防治产品市场按产品类型、动物类型、分销管道和剂型划分－全球预测，2025-2032年

Flea, Tick, & Heartworm Products Market by Product Type, Animal Type, Distribution Channel, Form - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，跳蚤、蜱虫和心丝虫产品市场将成长至 33.3 亿美元，复合年增长率为 11.89%。

关键市场统计数据
基准年 2024 13.5亿美元
预计年份：2025年 15.1亿美元
预测年份 2032 33.3亿美元
复合年增长率 (%) 11.89%

以产品创新、渠道行为和饲主动态为重点方向，为跳蚤、蜱虫和心丝虫防治的策略重点提供资讯。

本执行摘要对目前影响伴侣动物跳蚤、蜱虫和心丝虫治疗的动态因素进行了简洁扼要的分析，旨在为商业领袖和决策者提供帮助。它综合分析了影响产品系列和市场推广重点的产品和通路发展、监管压力以及不断变化的护理模式。透过将产品配方和供应形式与分销行为和饲主的偏好相结合，本摘要重点阐述了渐进式创新和通路合作能够带来最大回报的领域。

本导言重点阐述了治疗效果、饲主便利性和兽医通路影响力之间的关键交会点。它强调，市场的发展不仅体现在活性成分和长效给药系统的技术进步上，也体现在购买路径的转变上，这种转变有利于数位化发现和专业零售商的影​​响。因此，相关人员必须平衡配方投资与通路策略以及上市后支持，以增强合规性和品牌信任。以下章节将探讨变革性转变、关税影响、细分市场细微差别、区域模式、竞争行为以及将洞察转化为业务优先事项的实用建议。

科学进步、饲主不断变化的期望以及全通路分销如何重塑产品系列、通路策略和监管重点？

跳蚤、蜱虫和心丝虫防治领域正经历着一场变革，这场变革的驱动力来自科学进步、饲主期望的提高以及分销渠道的演变，这些因素正在重塑投资和商业化模式。在产品方面，基于异噁唑啉化学和复合活性成分的长效项圈和新一代滴剂，透过减少给药频率和简化治疗方案，正在改变宠物主人的用药依从性。

同时，优质化和预防保健理念的兴起推动了对差异化产品形式的需求，例如强调偏好和便利性的药用洗髮精和软嚼片。因此，各公司正在重新调整产品组合，纳入跳蚤控制产品（例如，传统项圈和长效项圈、咀嚼片和软嚼片、药用洗髮精和普通洗髮精、多种滴剂（如Fipronil、Imidacloprid、异噁唑啉和塞拉菌素）以及气雾剂和泵式喷雾剂）、注射剂和口服螨剂、剂剂和口服药剂形式的犬滴剂。

在分销方面，全通路化正在改变宠物用品的取得管道和价格透明度。宠物饲主越来越多地透过品牌官网和电商平台在线搜寻产品讯息，同时也重视兽医诊所的专业服务，从而形成了一种混合式的购买路径。包括药局和超级市场的量贩店通路持续吸引註重性价比的消费者，而实体宠物专卖店和线上宠物专卖店则在产品种类和专业性方面展开竞争。兽医诊所仍然具有影响力，但集团公司和独立诊所在采购方式和客户沟通方面逐渐出现差异。因此，企业必须优化通路策略，以更能反映消费者研究的接点、日常购买模式以及兽医的建议。

最后，监管审查和对活性成分生命週期的考量正促使製造商加快对替代化学成分和给药机制的研究。技术创新、通路转变和监管压力三者交汇，正是当前变革的驱动力，研发、监管和商业部门必须协调一致地应对这项变革。

因应2025年关税政策带来的供应链转变和采购重组，以维持各通路的产品供应和商业竞争力

2025年关税政策发展的累积影响，正为跳蚤、蜱虫和犬心丝虫防治产品相关人员的采购、定价和供应链策略带来新的复杂性。关税的变化将影响原料药投入、二次包装和成品流通，迫使采购团队重新评估其供应商布局和合约条款。特别是，依赖跨境原料药供应链或进口成品分销到国内市场的製造商，将不得不应对更高的到岸成本和更长的前置作业时间。

为此，各公司正在加速推动近岸外包和双重采购策略，以降低单一来源风险并减轻关税波动的影响。此类策略调整会影响产品组合决策，包括项圈、口服药片、洗髮精、滴剂、喷雾剂以及其他跳蚤和心丝虫预防注射剂、口服药片和蜱虫防治产品。采购结构调整也会影响包装选择，更轻、更紧凑的包装形式可以降低关税负担并提高履约效率。

此外，关税也凸显了通路组合优化的重要性。面对不断上涨的采购成本，零售商和经销商可能会调整产品组合，转向利润率更高的商品和自有品牌解决方案，从而影响产品在量贩店、宠物专卖店和线上市场的可见度。同样面临库存成本压力的兽医诊所，可能会加快采用直接面向消费者的履约模式和订阅服务，以维持客户忠诚度并降低价格敏感度。总而言之，2025年的关税环境既推动了短期营运应对措施，也促使企业在采购和分销方面进行长期结构性调整，企业必须将这些调整纳入其策略规划。

将产品形式、动物用途、通路、配方选择等因素连结起来的多层次细分框架，能够实现更有针对性的商业化和研发决策。

透过精细化的市场细分，可以揭示产品类型、动物类型、通路和剂型等方面的关键机会和权衡取舍，从而有助于产品组合的优先排序和通路投资决策。依产品类型划分，跳蚤防治产品涵盖多种给药途径，包括项圈（长效项圈和传统项圈）、咀嚼片和软咀嚼片、药用洗髮精和普通洗髮精、含有Fipronil、Imidacloprid、异噁唑啉和塞拉菌素等化学成分的滴剂，以及气雾剂和泵式喷雾剂。犬心丝虫预防产品分为注射液和口服锭剂，而蜱虫防治产品则包括项圈、口服药片和滴剂。如此丰富的产品频谱需要针对研发优先事项和行销策略采取细緻入微的方法，因为功效、持续时间、偏好和饲主便利性是影响各细分市场产品采纳的关键因素。

物种细分能够进一步优化目标群体和通讯。在猫科动物中，室内/室外饲养会影响人们对暴露风险的认知，进而影响预防药物的选择和使用频率。在犬类中，体型分类（例如大型犬和小型犬）会影响给药方案、给药器设计以及相关的沟通讯息，以减少用药错误。这些动物应用案例直接影响药物配方和包装的选择，并且需要客製化的教育材料来解答饲主对安全性和实用性的担忧。

细分分销管道凸显了不同通路在购买行为和利润结构上的差异。量贩店，包括药局和超级市场，凭藉规模优势和便利性吸引註重性价比的消费者；而线上零售商则透过品牌网站和以便利性和订阅模式为核心的电商平台，吸引习惯于数位原民购物的消费者。宠物专卖店（包括实体店和网店）提供精心挑选的产品和专业知识，而兽医诊所（区分集团诊所和独立诊所）则提供临床支援和麵对面咨询服务。由于通路经济效益和客户信任度各不相同，製造商需要针对每个管道量身定制产品组合、促销和培训计划，以最大限度地扩大覆盖率和提高转换率。

基于剂型的细分进一步优化了竞争策略。项圈、注射、口服剂、洗髮精、喷雾剂和外用剂的研发週期、监管路径和利润率各不相同。口服剂型又分为咀嚼片、软咀嚼片和传统片剂，而外用剂型则包括滴剂、外用洗髮剂和外用喷雾剂。了解这些剂型如何与饲主的偏好、兽医的建议以及用药依从性相符，对于制定以依从性和客户终身价值为优先的上市策略至关重要。将这些细分维度结合起来，可以建立一个多层次的市场图，清楚地展现出在创新、通路支援和客户教育方面的投资能够释放最大商业性潜力的领域。

区域监管的复杂性、通路成熟度和消费者行为模式将塑造全球各区域差异化的市场策略

区域动态对监管环境、通路发展和所有者行为有显着影响，因此了解区域差异对于精准的市场执行至关重要。在美洲，完善的监管路径和成熟的兽医零售基础设施为诊所的强大影响力提供了支撑，但线上管道的普及和大众市场零售管道的出现，催生了一种混合型的购买模式，需要量身定制的全通路策略。支付偏好和订阅渗透率也因细分市场而异，进而影响预防性药物的最佳管道组合。

在欧洲、中东和非洲，监管和区域性产品註册要求正在影响产品的上市时间和剂型选择。同时，该地区部分市场的高度分散性也要求选择性的分销策略和适应性包装。在许多欧洲市场，兽医网路对临床应用保持高度信心，这支持了部分地区诊所主导的新型化学製剂和注射型犬心丝虫预防药物的应用。同时，中东和非洲市场在宠物饲养量增加和都市化的推动下展现出巨大的成长潜力，但物流和监管方面的复杂性要求谨慎选择合作伙伴。

亚太地区的市场成熟度各不相同。已开发国家的线上零售业发展迅猛，对优质便捷的零售模式需求日益增长；而新兴市场则正逐步从非正式零售模式转向以宠物专卖店和兽医诊所为中心的正规管道。由于各国的供应链考量和监管环境存在差异，企业需要采取差异化的参与策略、在地化配方以及针对不同区域的优化定价和促销策略。在所有地区，产品设计和通路策略与当地兽医诊疗模式和饲主的期望相契合，对于产品的推广和持续销售仍然至关重要。

不断变化的竞争格局将决定传统临床品牌、专业参与企业和通路整合之间的策略差异化和覆盖范围。

跳蚤、蜱虫和犬心丝虫防治领域的竞争动态呈现出多元化的态势，既有传统创新企业，也有灵活敏捷的专业品牌、契约製造和兽医渠道供应商，它们各自采取不同的市场策略。传统创新企业倾向于利用已建立的临床证据和强大的兽医关係来巩固其高端市场地位，而专业品牌则专注于配方差异化、提升偏好和生活方式顾客购买倾向率，以赢得零售和线上管道的青睐。契约製造和自有品牌的进入加剧了大众市场通路的价格竞争，迫使品牌所有者更加重视临床数据和服务提案，以保障利润。

策略性倡议还包括合作与授权协议，这些协议能够加速获取新的活性成分，或在无需承担本地基础设施全部成本的情况下实现地理扩张。此外，一些公司正在尝试订阅和合规服务，将产品补充装与提醒和兽医随访相结合，以提高用户依从性和终身价值。与宠物专卖零售商和线上市场的通路伙伴关係也越来越多地融入共同行销和数据共用，以提升目标定位和转换率。总而言之，这些企业级策略凸显了协调研发蓝图、生产弹性、通路奖励和售后服务对于维持竞争优势的重要性。

制定可执行的策略重点，以协调配方创新、通路差异化和供应链韧性，从而加速产品推广并保障商业性利润。

产业领导者应推行协作策略，将产品创新、通路执行和供应链韧性结合，以掌握当前机会并降低系统性风险。首先，应优先研发能减少给药频率、简化用药方式的配方和剂型，例如缓释项圈和偏好极佳的软咀嚼片。同时，应增加对兽医专业人员和饲主的教育投入，内容涵盖给药准确性、不同物种（室内猫与室外猫、大型犬与小型犬）的安全性以及不同剂型的相对优势等主题。

其次，优化通路策略，针对每个通路量身订做产品组合和促销方式。对于包括药局和超级市场在内的量贩店，应强调符合消费者需求的性价比和便利包装。对于线上管道，应优化品牌网站体验和电商平台商品讯息，以促进订阅用户和实现无缝补货。对于宠物专卖店和兽医诊所，应提供客製化培训和店内促销物料，透过强调临床优势和服务组合来提升转换率。第三，透过近岸外包、多元化采购和简化包装来强化供应链架构，从而降低关税影响并缩短前置作业时间，同时利用合约製造外包关係，在需求波动时快速扩大产能。

最后，要拥抱数据驱动的商业化，将销售点洞察、订阅指标和投注回馈整合到迭代的产品和行销调整中。在全面推广之前，利用试点计画测试不同的定价结构、包装创新和客户支援服务。透过将研发重点与通路经济效益和营运保障措施结合，产业领导者可以提供卓越的客户体验，保障利润，并加速产品类型和地理的普及。

采用混合研究途径，结合从业者访谈、文献分析和情境映射，以检验细分和管道主导的洞察。

本研究采用综合调查方法，结合一手和二手资料以及供应链评估，以确保研究结果的稳健性和多方验证。一手资料研究包括对来自企业和独立诊所的兽医专业人士、量贩店和宠物专卖店的采购和品类经理，以及品牌商和製造外包组织的管理人员进行结构化访谈，以获取关于产品选择驱动因素、通路经济效益和监管摩擦点的第一手观点。除了访谈外，我们还对线上零售商品资讯、品牌网站和市场定位进行观察性审查，以评估通讯、定价结构和订阅模式的接受度。

二次检验涵盖了监管文件、专利文件、投入成本趋势和物流报告，以评估活性成分的生命週期、包装影响以及关税的影响。我们反覆检验假设，以完善市场区隔结论和区域差异分析。分析技术包括对访谈记录进行定性编码、情境映射以评估关税和供应链突发情况，以及渠道行为建模以推断不同产品形式和动物使用案例的可能路径。这种混合方法确保了建议是基于实务经验，并得到可观察的市场讯号的支持。

一份简洁的综合报告，将产品创新、通路适用性和营运准备作为宠物预防保健领域持续商业性成功的三大支柱。

总之，跳蚤、蜱虫和心丝虫的治疗市场正处于曲折点，配方创新、渠道演变以及关税调整等外部压力正在重新定义竞争优势。那些能够将长期有效、便于饲主的剂型与严谨的临床证据相结合，同时优化通路伙伴关係并强化供应链的公司，将更有利于获得持久的市场认可。此外，按产品类型、动物用途、通路和剂型对市场进行细分，可以为研发、行销和营运投资的优先排序提供切实可行的蓝图。

各组织在将这些洞见融入策略规划时，应着重製定灵活的商业化蓝图、进行前导测试，并积极与监管机构沟通，以加快产品上市速度，并增强兽医专业人士和宠物饲主的信心。展望未来，需要进行协调一致的跨部门行动，将这些洞见转化为可衡量的成果。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 消费者越来越偏好选择每月服用一次的异噁唑啉口服咀嚼片，这种咀嚼片可以同时提供跳蚤和蜱虫的防护。
  • 扩大全年预防心丝虫的订阅和自动配送模式，以提高宠物饲主的便利性。
  • 植物来源和天然驱螨剂正日益成为化学杀螨剂的替代品。
  • 整合远端医疗兽医服务和远端寄生虫预防订购可提高依从性
  • 市场对可简化跳蚤、蜱虫和心丝虫治疗流程的多宠物家庭用药系统的需求激增。
  • 人们越来越关注杀螨剂抗药性问题，促使人们研究新的联合治疗和轮换用药通讯协定。
  • 环境永续性的努力促使製造商为其每月使用的杀寄生虫剂采用环保包装。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的跳蚤、蜱虫和心丝虫产品市场

  • 跳蚤防治
    • 衣领
      • Nonseraecto 领
      • 赛拉克
    • 口服锭剂
      • 咀嚼片
      • 软嚼片
    • 洗髮精
      • 药用
      • 通常
    • 完全正确
      • FipronilImidacloprid
      • 异噁唑啉
      • 塞拉菌素
    • 喷
      • 气雾剂
      • 泵式喷雾
  • 预防犬心丝虫
    • 注射
    • 口服锭剂
  • 蜱虫控制
    • 衣领
    • 口服锭剂
    • 完全正确

9. 依动物类型分類的跳蚤、蜱虫和心丝虫产品市场

  • 猫
    • 室内猫
    • 户外猫
  • 狗
    • 大型犬
    • 小型犬

10. 跳蚤、蜱虫和心丝虫产品市场（依分销管道划分）

  • 量贩店
    • 药局
    • 超级市场
  • 线上零售商
    • 品牌网站
    • 市场
  • 宠物专卖店
    • 限实体店
    • 仅限线上
  • 兽医诊所
    • 企业诊所
    • 独立诊所

11. 依形式分類的跳蚤、蜱虫和心丝虫产品市场

  • 衣领
  • 注射
  • 口服
    • 咀嚼片
    • 软嚼片
    • 药片
  • 洗髮精
  • 喷
  • 外用药物
    • 完全正确
    • 局部洗髮精
    • 外用喷雾剂

12. 各地区跳蚤、蜱虫及心丝虫产品市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

13. 按群体分類的跳蚤、蜱虫和心丝虫产品市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各国跳蚤、蜱虫和心丝虫产品市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Zoetis Inc.
    • Merck & Co., Inc.
    • Elanco Animal Health Incorporated
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale SA
    • Vetoquinol SA
    • Virbac SA
    • Dechra Pharmaceuticals PLC
    • Animal Health International, Inc.
    • Nutramax Laboratories Veterinary Sciences, LLC
Product Code: MRR-B9334AD6C37E

The Flea, Tick, & Heartworm Products Market is projected to grow by USD 3.33 billion at a CAGR of 11.89% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.35 billion
Estimated Year [2025] USD 1.51 billion
Forecast Year [2032] USD 3.33 billion
CAGR (%) 11.89%

A focused orientation that aligns product innovations, channel behavior, and pet owner dynamics to inform strategic priorities for flea, tick, and heartworm interventions

The companion executive summary presents a concise, analytically driven orientation to current dynamics shaping flea, tick, and heartworm products across companion animals, framed to support commercial leaders and decision makers. It synthesizes product and channel developments, regulatory pressures, and shifting care patterns that collectively influence product portfolios and go-to-market priorities. By situating product formulations and delivery formats alongside distribution behavior and animal owner preferences, the narrative highlights where incremental innovation and channel alignment yield the greatest returns.

This introduction foregrounds the critical intersections between therapeutic efficacy, owner convenience, and vet channel influence. It emphasizes that the market is evolving not only through technological advances in active ingredients and long-duration delivery systems but also through changing purchasing pathways that favor digital discovery and specialty retail influence. Consequently, stakeholders must balance formulation investment with channel strategies and post-launch support that reinforce compliance and brand trust. The following sections expand on transformative shifts, tariff implications, segmentation nuances, regional patterns, competitive behavior, and pragmatic recommendations to translate insight into operational priorities.

How scientific advances, evolving owner expectations, and omnichannel distribution are jointly reshaping product portfolios, channel strategies, and regulatory priorities

The landscape for flea, tick, and heartworm interventions is undergoing transformative shifts driven by scientific advances, owner expectations, and distribution evolution that together redirect investment and commercialization patterns. On the product front, long-duration collars and next-generation spot-on formulations built on isoxazoline class chemistry and combination actives are changing adherence dynamics by reducing dosing frequency and simplifying regimens, which in turn alters how veterinarians and retailers frame product value during consultations.

Simultaneously, the rise of premiumization and preventive wellness positions has increased demand for differentiated formats such as medicated shampoos and soft chew oral tablets that emphasize palatability and convenience. As a result, companies are rebalancing portfolios across Flea Control formats - collar variants including legacy and long-lasting options, oral tablets in chewable and soft chew forms, medicated and regular shampoos, multiple spot-on chemistries like fipronil imidacloprid, isoxazoline, and selamectin, and sprays available as aerosol and pump formats - as well as Heartworm Prevention delivered via injectable and oral tablets and Tick Control options spanning collars, oral tablets, and spot-on treatments.

In distribution, omnichannel behaviors are reshaping access and pricing transparency. Pet owners increasingly research options online via brand websites and marketplaces while still valuing in-clinic reassurance from veterinary professionals, resulting in a hybrid purchase journey. Mass market retail channels, including pharmacies and supermarkets, continue to offer reach for value-focused buyers, whereas pet specialty stores-both brick-and-mortar and online-compete on assortment and expertise. Veterinary clinics remain influential, with distinctions emerging between corporate clinic groups and independent practices in purchasing practices and client communication. Consequently, companies must refine channel strategies to reflect consumer research touchpoints, subscription buying patterns, and veterinary recommendations.

Finally, regulatory scrutiny and active ingredient lifecycle considerations are prompting manufacturers to accelerate research into alternative chemistries and delivery mechanisms. This intersection of innovation, channel migration, and regulatory pressure is the engine of the current transformation and requires coordinated responses across R&D, regulatory affairs, and commercial functions.

Navigating 2025 tariff-induced supply chain shifts and procurement realignment to sustain product availability and commercial competitiveness across channels

The cumulative impact of tariff policy developments in 2025 has introduced additional complexity to sourcing, pricing, and supply-chain strategy for stakeholders across the flea, tick, and heartworm product spectrum. Tariff shifts affect raw material inputs, secondary packaging, and finished goods movements, prompting procurement teams to reevaluate supplier footprints and contract terms. In particular, manufacturers that rely on cross-border active pharmaceutical ingredient supply chains or that import finished products for distribution in domestic markets must adapt to increased landed costs and longer lead times.

In response, companies are accelerating nearshoring and dual-sourcing strategies to mitigate single-source exposure and to reduce the volatility associated with tariff episodes. These strategic adjustments influence product assortment decisions across Flea Control formats such as collars, oral tablets, shampoos, spot-on formulations, and sprays as well as Heartworm Prevention injectables and oral tablets and Tick Control offerings. Procurement realignment also impacts packaging choices, where lightweight and consolidated pack formats can reduce tariff burdens and improve fulfillment economics.

Moreover, tariffs have amplified the importance of channel mix optimization. Retailers and distributors facing higher procurement costs may shift assortment toward higher-margin items or private label solutions, affecting product visibility in mass market retail, pet specialty stores, and online marketplaces. Veterinary clinics likewise face pressure on clinic inventory economics, which can accelerate the adoption of direct-to-client fulfillment models or subscription services to maintain adherence while buffering price sensitivity. Taken together, the tariff environment of 2025 has prompted both short-term operational responses and longer-term structural shifts in sourcing and distribution that companies must integrate into strategic planning.

A layered segmentation framework linking product formats, animal use cases, distribution pathways, and formulation choices to inform targeted commercialization and R&D decisions

A granular segmentation lens reveals critical opportunities and tradeoffs across product type, animal type, distribution channel, and form that inform portfolio prioritization and channel investment decisions. By product type, Flea Control encompasses multiple delivery mechanisms including collars that split into long-duration variants and legacy options, oral tablets available as chewable tablet and soft chew, shampoos differentiated as medicated and regular, spot-on formats spanning chemistries such as fipronil imidacloprid, isoxazoline, and selamectin, and sprays offered in aerosol and pump formats. Heartworm Prevention divides into injectable solutions and oral tablets, while Tick Control is addressed through collars, oral tablets, and spot-on products. This product spectrum requires a nuanced approach to R&D prioritization and marketing narratives, since efficacy, duration, palatability, and owner convenience will determine adoption across segments.

Animal type segmentation further refines targeting and messaging. Within cats, indoor and outdoor distinctions shape perceived exposure risk and therefore influence preventive choices and frequency. For dogs, size classifications such as large breed and small breed inform dosing regimens, dispenser design, and collateral communications that reduce dosing errors. These animal use cases tie directly to formulation choices and packaging, and they necessitate tailored educational materials that address owner concerns about safety and practicality.

Distribution channel segmentation highlights divergent purchase behaviors and margin structures. Mass market retailers, which include pharmacies and supermarkets, deliver scale and accessibility for value-focused buyers, whereas online retailers attract digitally native shoppers through brand websites and marketplaces that emphasize convenience and subscription models. Pet specialty stores, both brick-and-mortar and online specialty shops, provide curated assortments and expertise while veterinary clinics-differentiated into corporate clinic groups and independent practices-offer clinical endorsement and in-person counsel. Channel economics and client trust levels vary, so manufacturers should calibrate product mix, trade promotions, and training programs by channel to maximize reach and conversion.

Formulation-based segmentation further refines competitive playbooks. Collars, injectables, oral formats, shampoos, sprays, and topicals each present distinct development timelines, regulatory pathways, and margin outcomes. Oral formats split into chewable tablet, soft chew, and traditional tablet, while topicals encompass spot-on applications, topical shampoos, and topical sprays. Understanding how these forms align with owner preference, veterinarian recommendation, and dosing adherence is essential to designing launch strategies that prioritize compliance and lifetime customer value. When combined, these segmentation axes create a layered map that clarifies where investment in innovation, channel support, and customer education will unlock the greatest commercial potential.

Regional regulatory complexity, channel maturity, and consumer behavior patterns shaping differentiated go-to-market strategies across global territories

Regional dynamics exert a significant influence on regulatory landscapes, channel development, and owner behavior, and recognizing geographic variation is essential for precise market execution. In the Americas, regulatory pathways and a well-established veterinary retail infrastructure support strong clinic influence, but increasing online adoption and the presence of mass market retail channels create hybrid purchase journeys that require coordinated omnichannel strategies. Payment preferences and subscription adoption rates also differ across submarkets, influencing the optimal channel mix for preventive products.

In Europe, Middle East & Africa, regulatory scrutiny and localized product registration requirements shape launch timing and formulation choices, while market fragmentation in parts of the region necessitates selective distribution strategies and adaptable packaging. Veterinary networks in many European markets maintain high clinical trust, which supports clinic-led adoption of novel chemistries and injectable heartworm prevention in select territories. Meanwhile, the Middle East and Africa present pockets of growth tied to rising pet ownership and urbanization, but logistical and regulatory complexities require careful partner selection.

Asia-Pacific exhibits diverse market maturity across countries, with advanced economies demonstrating rapid online retail growth and growing demand for premium, convenience-oriented formats, while emerging markets show a gradual shift from informal retail to structured pet specialty and veterinary channels. Supply chain considerations and regulatory alignment vary by country, prompting companies to adopt differentiated entry strategies, localized formulations, and regionally optimized pricing and promotional tactics. Across all regions, aligning product design and channel strategies with local veterinary practice patterns and owner expectations remains critical to adoption and sustained uptake.

An evolving competitive landscape where legacy clinical brands, specialty entrants, and channel-aligned strategies determine differentiation and defensive playbooks

Competitive dynamics in the flea, tick, and heartworm space reflect a mixed landscape of legacy innovators, agile specialty brands, contract manufacturers, and veterinary channel suppliers that each pursue distinct routes to market. Legacy innovators tend to leverage established clinical evidence and strong veterinary relationships to defend premium positions, while specialty brands focus on formulation differentiation, palatability, and lifestyle positioning to capture retail and online mindshare. Contract manufacturing and private label entrants intensify price competition in mass market channels, prompting brand owners to emphasize clinical data and service propositions to preserve margin.

Strategic behaviors also include partnerships and licensing arrangements that accelerate access to novel active ingredients or enable geographic expansion without the full costs of local infrastructure. Additionally, companies are experimenting with subscription and compliance services that bundle product replenishment with reminders and veterinary follow-ups to increase adherence and lifetime value. Channel partnerships with pet specialty retailers and online marketplaces increasingly incorporate co-marketing and data sharing to improve targeting and conversion. Taken together, these company-level strategies underscore the importance of aligning R&D roadmaps, manufacturing flexibility, channel incentives, and post-sale services to sustain competitive advantage.

Actionable strategic priorities that align formulation innovation, channel differentiation, and supply chain resilience to accelerate adoption and protect commercial margins

Industry leaders should pursue a coordinated agenda that aligns product innovation, channel execution, and supply-chain resilience to capitalize on current opportunities and mitigate systemic risks. First, prioritize formulations and delivery formats that reduce dosing frequency and simplify administration, such as long-duration collars and palatable soft chew oral tablets, while maintaining rigorous safety and efficacy evidence to support veterinary endorsement. Simultaneously, invest in targeted education for both veterinary professionals and pet owners that addresses dosing accuracy, safety for different animal types such as indoor versus outdoor cats and large versus small breed dogs, and the comparative benefits of each form factor.

Second, optimize channel strategies by tailoring assortment and promotional approaches to each distribution pathway. For mass market retailers including pharmacies and supermarkets, emphasize value and packaging convenience that aligns with shopper priorities. For online channels, refine brand website experiences and marketplace listings to support subscription adoption and seamless replenishment. Pet specialty stores and veterinary clinics require bespoke training and point-of-sale materials that enhance conversion through demonstrated clinical benefits and service bundling. Third, fortify supply-chain architecture through nearshoring, diversified sourcing, and packaging rationalization to reduce tariff exposure and shorten lead times, while leveraging contract manufacturing partnerships to scale rapidly when demand fluctuates.

Finally, adopt data-centric commercialization by integrating point-of-sale insights, subscription metrics, and veterinary feedback into iterative product and marketing adjustments. Use pilot programs to test alternative pricing structures, packaging innovations, and adherence services before full rollouts. By synchronizing R&D priorities with channel economics and operational safeguards, industry leaders can deliver superior customer experiences, protect margin, and accelerate adoption across product types and regions.

A mixed-methods research approach integrating practitioner interviews, document analysis, and scenario mapping to validate segmentation and channel-driven insights

The underlying research methodology blends primary qualitative engagements with secondary document analysis and supply-chain assessment to ensure robustness and triangulation of insights. Primary research included structured interviews with veterinary professionals across corporate and independent clinics, procurement and category managers from mass market and pet specialty retailers, and executives from brand and contract manufacturing organizations to capture firsthand perspectives on product selection drivers, channel economics, and regulatory friction points. These interviews were complemented by observational reviews of online retail listings, brand websites, and marketplace positioning to assess messaging, pricing structure, and subscription adoption.

Secondary analysis encompassed regulatory filings, patent literature, input cost trends, and logistics reports to evaluate active ingredient lifecycles, packaging implications, and tariff exposure. Cross-validation occurred through synthesis of interview inputs and documentary evidence, with iterative hypothesis testing to refine segmentation implications and regional differentials. Analytical techniques included qualitative coding of interview transcripts, scenario mapping to evaluate tariff and supply-chain contingencies, and channel-behavior modeling to infer likely adoption pathways across product forms and animal use cases. This mixed-methods approach ensures that recommendations are grounded in practitioner experience and corroborated by observable market signals.

A concise synthesis that links product innovation, channel calibration, and operational preparedness as the pillars for sustained commercial success in preventive pet care

In conclusion, the flea, tick, and heartworm product landscape is at an inflection point where formulation innovation, channel evolution, and external pressures such as tariff shifts converge to redefine competitive advantage. Companies that integrate long-duration and owner-friendly delivery formats with rigorous clinical evidence, while simultaneously optimizing channel partnerships and fortifying supply chains, will be best positioned to capture durable adoption. Moreover, segmentation by product type, animal use case, distribution pathway, and form provides a practical blueprint for prioritizing investments in R&D, marketing, and operations.

As organizations translate these insights into strategic plans, they should emphasize adaptable commercialization road maps, pilot testing across channels, and proactive regulatory engagement to expedite product availability and reassure both veterinary professionals and pet owners. The path forward requires coordinated action across functions to convert insight into measurable outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing consumer preference for monthly oral isoxazoline chews offering dual flea and tick protection
  • 5.2. Expansion of subscription and auto-ship models for year-round heartworm prophylaxis providing convenience for pet owners
  • 5.3. Increased availability of plant-based and natural repellents as alternative options to chemical acaricides
  • 5.4. Integration of telehealth veterinary services with remote parasite prevention ordering boosting adherence rates
  • 5.5. Demand surge for multi-pet family dosing systems simplifying flea, tick, and heartworm treatment routines
  • 5.6. Emerging concerns over acaricide resistance driving research into novel combination therapies and rotating protocols
  • 5.7. Environmental sustainability initiatives leading manufacturers to adopt eco-friendly packaging for monthly parasiticides

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Flea, Tick, & Heartworm Products Market, by Product Type

  • 8.1. Flea Control
    • 8.1.1. Collar
      • 8.1.1.1. Non Seresto Collars
      • 8.1.1.2. Seresto
    • 8.1.2. Oral Tablet
      • 8.1.2.1. Chewable Tablet
      • 8.1.2.2. Soft Chew
    • 8.1.3. Shampoo
      • 8.1.3.1. Medicated
      • 8.1.3.2. Regular
    • 8.1.4. Spot On
      • 8.1.4.1. Fipronil Imidacloprid
      • 8.1.4.2. Isoxazoline
      • 8.1.4.3. Selamectin
    • 8.1.5. Spray
      • 8.1.5.1. Aerosol
      • 8.1.5.2. Pump Spray
  • 8.2. Heartworm Prevention
    • 8.2.1. Injectable
    • 8.2.2. Oral Tablet
  • 8.3. Tick Control
    • 8.3.1. Collar
    • 8.3.2. Oral Tablet
    • 8.3.3. Spot On

9. Flea, Tick, & Heartworm Products Market, by Animal Type

  • 9.1. Cat
    • 9.1.1. Indoor Cat
    • 9.1.2. Outdoor Cat
  • 9.2. Dog
    • 9.2.1. Large Breed Dog
    • 9.2.2. Small Breed Dog

10. Flea, Tick, & Heartworm Products Market, by Distribution Channel

  • 10.1. Mass Market Retailers
    • 10.1.1. Pharmacies
    • 10.1.2. Supermarkets
  • 10.2. Online Retailers
    • 10.2.1. Brand Websites
    • 10.2.2. Marketplaces
  • 10.3. Pet Specialty Stores
    • 10.3.1. Brick And Mortar Specialty
    • 10.3.2. Online Specialty
  • 10.4. Veterinary Clinics
    • 10.4.1. Corporate Clinic
    • 10.4.2. Independent Clinic

11. Flea, Tick, & Heartworm Products Market, by Form

  • 11.1. Collar
  • 11.2. Injectable
  • 11.3. Oral
    • 11.3.1. Chewable Tablet
    • 11.3.2. Soft Chew
    • 11.3.3. Tablet
  • 11.4. Shampoo
  • 11.5. Spray
  • 11.6. Topical
    • 11.6.1. Spot On
    • 11.6.2. Topical Shampoo
    • 11.6.3. Topical Spray

12. Flea, Tick, & Heartworm Products Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Flea, Tick, & Heartworm Products Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Flea, Tick, & Heartworm Products Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Zoetis Inc.
    • 15.3.2. Merck & Co., Inc.
    • 15.3.3. Elanco Animal Health Incorporated
    • 15.3.4. Boehringer Ingelheim International GmbH
    • 15.3.5. Ceva Sante Animale S.A.
    • 15.3.6. Vetoquinol S.A.
    • 15.3.7. Virbac S.A.
    • 15.3.8. Dechra Pharmaceuticals PLC
    • 15.3.9. Animal Health International, Inc.
    • 15.3.10. Nutramax Laboratories Veterinary Sciences, LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. FLEA, TICK, & HEARTWORM PRODUCTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. FLEA, TICK, & HEARTWORM PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. FLEA, TICK, & HEARTWORM PRODUCTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY FLEA CONTROL, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY FLEA CONTROL, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY FLEA CONTROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY FLEA CONTROL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY FLEA CONTROL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY FLEA CONTROL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY FLEA CONTROL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY FLEA CONTROL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COLLAR, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COLLAR, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COLLAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COLLAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COLLAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COLLAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COLLAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COLLAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY NON SERESTO COLLARS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY NON SERESTO COLLARS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY NON SERESTO COLLARS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY NON SERESTO COLLARS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY NON SERESTO COLLARS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY NON SERESTO COLLARS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SERESTO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SERESTO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SERESTO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SERESTO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SERESTO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SERESTO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CHEWABLE TABLET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CHEWABLE TABLET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CHEWABLE TABLET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CHEWABLE TABLET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CHEWABLE TABLET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CHEWABLE TABLET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SOFT CHEW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SOFT CHEW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SOFT CHEW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SOFT CHEW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SOFT CHEW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SOFT CHEW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SHAMPOO, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SHAMPOO, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SHAMPOO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SHAMPOO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SHAMPOO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SHAMPOO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SHAMPOO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SHAMPOO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MEDICATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MEDICATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MEDICATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MEDICATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MEDICATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MEDICATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY REGULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY REGULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY REGULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY REGULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY REGULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY REGULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPOT ON, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPOT ON, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPOT ON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPOT ON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPOT ON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPOT ON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPOT ON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPOT ON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY FIPRONIL IMIDACLOPRID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY FIPRONIL IMIDACLOPRID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY FIPRONIL IMIDACLOPRID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY FIPRONIL IMIDACLOPRID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY FIPRONIL IMIDACLOPRID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY FIPRONIL IMIDACLOPRID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ISOXAZOLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ISOXAZOLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ISOXAZOLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ISOXAZOLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ISOXAZOLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ISOXAZOLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SELAMECTIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SELAMECTIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SELAMECTIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SELAMECTIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SELAMECTIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SELAMECTIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPRAY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPRAY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY AEROSOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY AEROSOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY AEROSOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY AEROSOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY AEROSOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY AEROSOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PUMP SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PUMP SPRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PUMP SPRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PUMP SPRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PUMP SPRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PUMP SPRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY HEARTWORM PREVENTION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY HEARTWORM PREVENTION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY HEARTWORM PREVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY HEARTWORM PREVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY HEARTWORM PREVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY HEARTWORM PREVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY HEARTWORM PREVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY HEARTWORM PREVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY INJECTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY TICK CONTROL, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY TICK CONTROL, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY TICK CONTROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY TICK CONTROL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY TICK CONTROL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY TICK CONTROL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY TICK CONTROL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY TICK CONTROL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COLLAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COLLAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COLLAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COLLAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COLLAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY COLLAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ORAL TABLET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPOT ON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPOT ON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPOT ON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPOT ON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPOT ON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SPOT ON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CAT, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CAT, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CAT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CAT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CAT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CAT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CAT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CAT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY INDOOR CAT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY INDOOR CAT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY INDOOR CAT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY INDOOR CAT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY INDOOR CAT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY INDOOR CAT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY OUTDOOR CAT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY OUTDOOR CAT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY OUTDOOR CAT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY OUTDOOR CAT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY OUTDOOR CAT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY OUTDOOR CAT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY DOG, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY DOG, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY DOG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY DOG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY DOG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY DOG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY DOG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY DOG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY LARGE BREED DOG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY LARGE BREED DOG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY LARGE BREED DOG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY LARGE BREED DOG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY LARGE BREED DOG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY LARGE BREED DOG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SMALL BREED DOG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SMALL BREED DOG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SMALL BREED DOG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SMALL BREED DOG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SMALL BREED DOG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SMALL BREED DOG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MASS MARKET RETAILERS, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MASS MARKET RETAILERS, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MASS MARKET RETAILERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MASS MARKET RETAILERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MASS MARKET RETAILERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MASS MARKET RETAILERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MASS MARKET RETAILERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MASS MARKET RETAILERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SUPERMARKETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SUPERMARKETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SUPERMARKETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SUPERMARKETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SUPERMARKETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY SUPERMARKETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ONLINE RETAILERS, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ONLINE RETAILERS, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ONLINE RETAILERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ONLINE RETAILERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ONLINE RETAILERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ONLINE RETAILERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY BRAND WEBSITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY BRAND WEBSITES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY BRAND WEBSITES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY BRAND WEBSITES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY BRAND WEBSITES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY BRAND WEBSITES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MARKETPLACES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MARKETPLACES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MARKETPLACES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MARKETPLACES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MARKETPLACES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY MARKETPLACES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PET SPECIALTY STORES, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PET SPECIALTY STORES, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PET SPECIALTY STORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PET SPECIALTY STORES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PET SPECIALTY STORES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PET SPECIALTY STORES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PET SPECIALTY STORES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY PET SPECIALTY STORES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY BRICK AND MORTAR SPECIALTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY BRICK AND MORTAR SPECIALTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY BRICK AND MORTAR SPECIALTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY BRICK AND MORTAR SPECIALTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY BRICK AND MORTAR SPECIALTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY BRICK AND MORTAR SPECIALTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ONLINE SPECIALTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ONLINE SPECIALTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ONLINE SPECIALTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ONLINE SPECIALTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ONLINE SPECIALTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY ONLINE SPECIALTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY VETERINARY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CORPORATE CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CORPORATE CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CORPORATE CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CORPORATE CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CORPORATE CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY CORPORATE CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY INDEPENDENT CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY INDEPENDENT CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY INDEPENDENT CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL FLEA, TICK, & HEARTWORM PRODUCTS MARKET SIZE, BY INDEPENDENT CLINIC, BY GROUP, 2025-2032 (USD MILLIO